Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection (PHI-IMD).
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
Pilot study for the treatment of primary HIV infection with the objective to induce a strong
specific HIV immune response able to control viral replication without HAART.